Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07529691

Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Fibromuscular dysplasia (FMD) is a disease of the arteries that is not due to plaque build-up or inflammation. While some patients with FMD are health, some may experience heart attacks, strokes, aneurysms or blood vessel dissection/tearing which can be life-threatening. It predominantly impacts women and younger patients. As a result of this diagnosis, many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications. There are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This study will conduct a large, national survey of patients with FMD to assess the type of physical activity restrictions and impact on quality of life and emotional well-being.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location status: Recruiting

Location contact

Aaron W Aday, MD, MSc

SUB_INVESTIGATOR

Amanda M Morrison, MD

CONTACT

[email protected]

(615) 322-5000

Amanda M Morrison, MD

PRINCIPAL_INVESTIGATOR

CONTACT

[email protected]

About this study

Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory disease of medium-sized arteries characterized by intimal and medial hyperplasia. The exact prevalence of FMD is unknown, but it predominantly impacts women and middle-age patients, with a mean age of 52 at the time of diagnosis. The manifestations of FMD are variable and may include spontaneous coronary artery dissection (SCAD) as well as extra-coronary vascular abnormalities (EVAs), such as peripheral artery aneurysms or dissections. Many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications.3,4 However, there are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD in the available 2018 American Heart Association (AHA) Scientific statement or the 2019 first international consensus document on FMD. Recommendations are formed based on expert opinion, and may vary based on a variety of factors including severity of disease, treating institution, or sex. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This survey will be delivered electronically via RedCap to participants who self-identify as having a diagnosis of fibromuscular dysplasia. It will be the first to identify the breadth and content, as well as the impact, of physical activity recommendations provided by healthcare personnel to patients with FMD. Data gathered from this study will encourage the creation of an expert consensus document on recommendations for physical activity by FMD phenotype, which will have implications for patient education and empowerment for those living with FMD. This may also lead to areas of future intervention to mitigate adverse quality of life if identified.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants with a diagnosis of fibromuscular dysplasia
  • Age range = 18-100 years

Exclusion criteria

  • Subjects who have an inability to complete the electronic consent form or electronic survey for any reason
  • Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey

Treatment and study plan

Primary outcomes

  1. Clinician-Recommended Physical Activity Restrictions

    Time frame: Baseline

    Prevalence and type of clinician-recommended physical activity restrictions among patients diagnosed with fibromuscular dysplasia (FMD), including aerobic, resistance, and activity-specific limitations.

Secondary outcomes

  1. Self-Reported Change in Physical Activity Following Diagnosis

    Time frame: Baseline

    Change in physical activity behavior following FMD diagnosis based on patient self-report.

  2. Emotional Impact of Physical Activity Recommendations

    Time frame: Baseline

    Self-reported anxiety or depression to physical activity recommendations and/or disease-related limitations.

  3. Physical Impact of Activity Recommendations

    Time frame: Baseline

    Self-reported physical consequences (e.g. weight gain, sedentary lifestyle) associated with modification of activity level following FMD diagnosis.

Study contacts

Contact information is provided by the study sponsor or research team.

Amanda Morrison, MD

CONTACT

[email protected]

615-322-5000

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Collaborators

  • Fibromuscular Dysplasia Society of America

Registry information

Official study title

National Survey of Physical Activity Restrictions and Quality of Life Among Patients With Fibromuscular Dysplasia

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 14, 2026
Registry last updated
Apr 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.